宫颈癌脱落细胞RBL1启动子甲基化与患者放疗抵抗的关系-东南大学学报医学版

宫颈癌脱落细胞RBL1启动子甲基化与患者放疗抵抗的关系

单位：1. 保定市第一医院妇产科, 河北保定 071000;
2. 河北大学附属医院肿瘤科, 河北保定 071000

分类号：R737.33

出版年·卷·期（页码）：2022·41·第二期（198-203）

摘要：

目的:探究宫颈癌脱落细胞视网膜母细胞瘤样蛋白1(RBL1)启动子甲基化状态与宫颈癌患者放疗抵抗的相关性。方法:选取2015年5月至2017年4月间保定市第一医院收治的82例宫颈癌患者,接受同步放化疗一线治疗。分别于放疗前(T0)、放疗中期(T1)、放疗结束(T2)采用定量甲基化特异性PCR法检测宫颈脱落细胞RBL1基因启动子甲基化扩增曲线交叉点变化值(ΔCp值)。根据监测3个月的治疗反应,获得完全缓解或部分缓解者纳入敏感组,否则纳入抵抗组。采用多因素Logistic回归模型和受试者工作特征(ROC)曲线分析RBL1基线甲基化对放疗抵抗的预测价值。结果:抵抗组患者各时间点RBL1基因启动子甲基化ΔCp值均低于敏感组(P＜0.001),T1、T2时的ΔCp值较基线值变化率均大于敏感组(P＜0.001)。RBL1基线启动子甲基化是影响宫颈癌患者产生放疗抵抗的独立危险因素(P＜0.05),其ΔCp值预测宫颈癌患者产生放疗抵抗的ROC曲线下面积为0.794(95%CI为0.697~0.892)。结论:RBL1启动子甲基化与宫颈癌患者放疗抵抗有关,监测RBL1甲基化的动态变化有助于优化宫颈癌的个体化治疗方案。

Objective: To investigate the correlation between the retinoblastoma-like 1(RBL1) promoter methylation status of exfoliated cervical cancer cells and radioresistance in patients with cervical cancer. Methods: From May 2015 to April 2017, 82 patients with cervical cancer admitted to Baoding First Hospital were selected and treated with concurrent chemo-radiotherapy as the first-line schedule. The crossing point change value of amplification curve(ΔCp) of RBL1 gene promoter methylation before radiotherapy(T0), at medium-term(T1) and at the end(T2) of radiotherapy were detected by quantitative methylation-specific PCR respectively. Patients were followed up for 3 months to monitor treatment response. Patients with completed response or partial response were selected as sensitivity group while those without any response were enrolled in resistance group. Multivariate Logistic regression model and receiver operating characteristic(ROC) curve were used to analyze the predictive value of baseline RBL1 methylation on the radioresistance. Results: The RBL1 gene promoter methylation ΔCp in the resistance group was lower than that in the sensitive group at each time point(P＜0.001). And the change rate of ΔCp from baseline at T1 and T2 in the resistant group was higher than that in the sensitive group(P＜0.001). The baseline hypermethylation of RBL1 promoter was independent risk factor for radiotherapy resistance in patients with cervical cancer(P＜0.05). The area under ROC curve of baseline RBL1 promoter methylation ΔCp for predicting the radiotherapy resistance was 0.794(95%CI0.697-0.892). Conclusion: The RBL1 gene promoter methylation status is related to radiotherapy sensitivity in patients with cervical cancer. Monitoring the dynamic changes of RBL1 methylation is helpful to optimize individualized treatment.

参考文献：

[1] 何旻,谢南子,陈观美,等.p16和Ki67在宫颈癌癌前病变及宫颈癌中表达及其与HPV感染的相关性[J].中国老年学杂志,2020,40(4):763-766.
[2] OLUSOLA P,BANERJEE H N,PHILLEY J V,et al.Human papilloma virus-associated cervical cancer and health disparities[J].Cells,2019,8(6):622.
[3] YANG J,CAI H,XIAO Z X,et al.Effect of radiotherapy on the survival of cervical cancer patients:an analysis based on SEER database[J].Medicine(Baltimore),2019,98(30):e16421.
[4] 傅志超,程惠华,廖绍光,等.CXCL12对宫颈癌细胞放射敏感性影响的实验研究[J].临床肿瘤学杂志,2017,22(11):968-972.
[5] ALESSIO N,CAPASSO S,DI BERNARDO G,et al.Mesenchymal stromal cells having inactivated RB1 survive following low irradiation and accumulate damaged DNA:hints for side effects following radiotherapy[J].Cell Cycle,2017,16(3):251-258.
[6] PAN D,CHEN Y,DU Y,et al.Methylation of promoter of RBL1 enhances the radioresistance of three dimensional cultured carcinoma cells[J].Oncotarget,2017,8(3):4422-4435.
[7] 陈华.高原地区老年宫颈癌组织中HIF-1α、ICAM-3的表达及与放疗敏感性的关系[J].中国老年学杂志,2019,39(1):47-49.
[8] 张睿怡.基因甲基化修饰对宫颈癌病变影响的研究进展[J].中国计划生育学杂志,2018,26(7):639-642.
[9] KIM K B,KIM Y,RIVARD C J,et al.FGFR1 is critical for RBL2 loss-driven tumor development and requires PLCG1 activation for continued growth of small cell lung cancer[J].Cancer Res,2020,80(22):5051-5062.
[10] KENNEDY A L,RAI R,ISINGIZWE Z R,et al.Complementary targeting of Rb phosphorylation and growth in cervical cancer cell cultures and a xenograft mouse model by SHetA2 and palbociclib[J].Cancers(Basel),2020,12(5):1269.
[11] HAN S,SHI X,LIU L,et al.Roles of B7-H3 in cervical cancer and its prognostic value[J].J Cancer,2018,9(15):2612-2624.
[12] ULLAH F,KHAN T,ALI N,et al.Promoter methylation status modulate the expression of tumor suppressor(RbL2/p130) gene in breast cancer[J].PLoS One,2015,10(8):e0134687.
[13] 潘冉冉,季慧慧,黄天怡,等.基于TCGA数据库结肠癌RBL1基因甲基化水平的诊断与预后分析[J].中国细胞生物学学报,2019,41(2):235-242.
[14] WU N Y,ZHANG X,CHU T,et al.High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis[J].Ann Transl Med,2019,7(14):328.
[15] 沈兰,陈春华,叶冬云,等.ESR1、MYOD1和hTERT基因启动子DNA甲基化与宫颈癌放化疗敏感性的关系[J].河北医药,2020,42(1):33-37.
[16] MIOUSSE I R,EWING L E,KUTANZI K R,et al.DNA methylation in radiation-induced carcinogenesis:experimental evidence and clinical perspectives[J].Crit Rev Oncog,2018,23(1-2):1-11.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录